RSC Bay Area Is First in the Nation to Deploy FDA-Cleared AI for Embryo Assessment by Alife Health, Pioneering a New Standard in IVF Care
In a first for U.S. reproductive medicine, RSC Bay Area and Alife Health bring AI-powered embryo assessment from clinical trial to patient care — setting a new benchmark for what technology-forward fertility treatment looks like. SAN FRANCISCO and LOS ANGELES, June 2, 2026 /PRNewswire/ --...
In a first for U.S. reproductive medicine, RSC Bay Area and Alife Health bring AI-powered embryo assessment from clinical trial to patient care — setting a new benchmark for what technology-forward fertility treatment looks like. SAN FRANCISCO and LOS ANGELES, June 2, 2026 /PRNewswire/ --...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.